Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio" or the "Company"), a clinical-stage, multi-asset immunology company developing ...

Chamath Palihapitiya, dubbed Wall Street's "SPAC king" for his high-profile blank-check deals, is set to take his latest ...

Tether has a market cap of $167 billion, but its history of compliance questions puts its regulatory future in doubt.

The most closely watched hiring contest in crypto has a winner. Former senior White House official Bo Hines, whose departure ...

Healthcare company KindlyMD said Tuesday that it spent $679 million buying Bitcoin, and its stock is down over 13% since.

Pro-XRP lawyer Bill Morgan criticized Tether for having an independent third-party custodian for its reserves, while praising ...

Cantor Fitzgerald analyst C J Muse reaffirmed a buy rating on NVIDIA, raising the target price from $200 to $240. This adjustment reflects NVIDIA's robust performance in the tech sector, particularly ...

Nvidia is set to beat expectations, with strong revenue forecast of $48b for Q2 and expected growth through 2026, driven by demand for AI and new Blackwell architecture.

Dominari was new to the finance game when it took office space in Trump Tower. Now it’s a key adviser on the first family’s ...

Chamath Palihapitiya is raising $250M for a new SPAC focusing on DeFi and AI. Steven Trieu will lead as CEO with Palihapitiya as chairman.

BBIO's Acoramidis shows promise but faces tough competition. Diverse pipeline & catalysts ahead, but valuation relies on ...